C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 85 filers reported holding C4 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,630 | -39.9% | 14,855 | -11.2% | 0.00% | – |
| Q2 2023 | $46,008 | -4.5% | 16,730 | +9.0% | 0.00% | – |
| Q1 2023 | $48,174 | -62.9% | 15,342 | +3.5% | 0.00% | -100.0% |
| Q3 2022 | $130,000 | +16.1% | 14,822 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $112,000 | -68.9% | 14,822 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $360,000 | -43.4% | 14,822 | -25.0% | 0.00% | -50.0% |
| Q4 2021 | $636,000 | -46.0% | 19,762 | -25.0% | 0.00% | -60.0% |
| Q3 2021 | $1,177,000 | +18.1% | 26,349 | 0.0% | 0.01% | +11.1% |
| Q2 2021 | $997,000 | +24825.0% | 26,349 | +24297.2% | 0.01% | – |
| Q1 2021 | $4,000 | – | 108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |